Lange, Kristin Sophie http://orcid.org/0000-0002-8056-8514
Tuloup, Gabrielle
Duflos, Claire
Gobron, Claire
Burcin, Cécilia
Corti, Lucas
Roos, Caroline
Ducros, Anne
Mawet, Jérôme
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 7 March 2023
Revised: 3 April 2023
Accepted: 5 April 2023
First Online: 13 April 2023
Declarations
:
: KSL received travel and accommodation expenses from Acticor Biotech and Teva, not related to the submitted work. CR received honoraria for board membership and speaker fees Allergan/Abbvie, Homeperf, Lilly, Lundbeck, Mylan, Novartis, Ophtalmic, Orkyn, Pfizer, Sanofi and Teva, and travel, accommodation, and meeting expenses from Teva, Lundbeck and Lilly, all outside the submitted work. AD received honoraria for board membership and speaker fees from Allergan Abbvie, Lilly, Teva, Lundbeck, Pfizer and travel, accommodation, and meeting expenses from Teva, and SOS Oxygène, all outside the submitted work; she is associate editor of Cephalalgia. JM received travel, accommodation, and meeting expenses from SOS, GEP Sante, Lundbeck and Homeperf and received honoraria for advisory boards or speaker fees from Abbvie, Teva, Lilly, Lundbeck and Novartis not related to the submitted work; he is a member of the redaction committee of “La Lettre du Neurologue” without financial compensation. The other authors report no conflicts of interest.
: Verbal informed consent was obtained from the prospectively recruited patients for their anonymized information to be published. Informed consent was waived for the retrospectively included patients.
: The <i>Commission Nationale Informatique et Liberté</i> and the local ethics committee of the University Hospital Montpellier approved this study (REC number: 202100733).
: KSL.